Does cabergoline improve cognition and attention more than placebo in healthy volunteers and what does this tell us about mechanisms of attention?

• Conditions: Executive control in healthy volunteers; Mental Health - Studies of normal psychology, cognitive function and behaviour; Neurological - Studies of the normal brain and nervous system

• Registration Number: ACTRN12611000604909
• Lead Sponsor: The University of Queensland

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-06-10
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: Male
• Target Recruitment: 24

Inclusion Criteria

Healthy volunteers
Aged 18 -40 years
Male

Exclusion Criteria

Current psychiatric or neurological illness
Current use of psychotropic medication
CUrrent substance use or dependence
Medical illness that is a contraindication for cabergoline use

Study & Design

• Study Type: Interventional
• Study Design: Not specified